Rivastigmine Sandoz 9.5mg/24 hours Transdermal Patch Īrija - angļu - HPRA (Health Products Regulatory Authority)

rivastigmine sandoz 9.5mg/24 hours transdermal patch

rowex ltd - rivastigmine - transdermal patch - 9.5 milligram(s)/24 hours - anticholinesterases; rivastigmine

Rivastigmine Sandoz 4.6mg/24 hours Transdermal Patch Īrija - angļu - HPRA (Health Products Regulatory Authority)

rivastigmine sandoz 4.6mg/24 hours transdermal patch

rowex ltd - rivastigmine - transdermal patch - 4.6 milligram(s)/24 hours - anticholinesterases; rivastigmine

Rivastigmine 1.5 mg hard capsules Īrija - angļu - HPRA (Health Products Regulatory Authority)

rivastigmine 1.5 mg hard capsules

accord healthcare ireland ltd. - rivastigmine - capsule, hard - 1.5 milligram(s) - anticholinesterases; rivastigmine

Rivastigmine 3 mg hard capsules Īrija - angļu - HPRA (Health Products Regulatory Authority)

rivastigmine 3 mg hard capsules

accord healthcare ireland ltd. - rivastigmine - capsule, hard - 3 milligram(s) - anticholinesterases; rivastigmine

Rivastigmine 4.5 mg hard capsules Īrija - angļu - HPRA (Health Products Regulatory Authority)

rivastigmine 4.5 mg hard capsules

accord healthcare ireland ltd. - rivastigmine - capsule, hard - 4.5 milligram(s) - anticholinesterases; rivastigmine

Rivastigmine 6 mg hard capsules Īrija - angļu - HPRA (Health Products Regulatory Authority)

rivastigmine 6 mg hard capsules

accord healthcare ireland ltd. - rivastigmine - capsule, hard - 6 milligram(s) - anticholinesterases; rivastigmine

EXELON 1.5 MG Izraēla - angļu - Ministry of Health

exelon 1.5 mg

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

EXELON 3 MG Izraēla - angļu - Ministry of Health

exelon 3 mg

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

EXELON 4.5 MG Izraēla - angļu - Ministry of Health

exelon 4.5 mg

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

EXELON 6 MG Izraēla - angļu - Ministry of Health

exelon 6 mg

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.